Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.69%)
As of: Sep 9, 2026 · 2:33 PM EDT

Viatris (VTRS) Other Non Operating Income (2019 - 2026)

Viatris (VTRS) posted Other Non Operating Income of $50.4 million for Q2 2026, up 206.11% on a QoQ basis from -$47.5 million in Q1 2026, and up 115.11% year-over-year from $23.4 million in Q2 2025.

Analysis

Viatris (VTRS) Other Non Operating Income (2019 - 2026) Analysis & Trends

Viatris has reported Other Non Operating Income for 8 years, with the latest figure at $50.4 million in Q2 2026.

  • On a quarterly basis, Other Non Operating Income rose 115.11% year-over-year to $50.4 million in Q2 2026; TTM through Jun 2026 was -$94.9 million, a 77.36% increase from a year earlier, with the FY2025 full-year figure at -$530.6 million, down 536.97% from the prior year.
  • Other Non Operating Income was $50.4 million for Q2 2026 at Viatris, up from -$47.5 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $1.8 billion in Q4 2022, with the low at -$333.5 million in Q2 2025.
  • Average Other Non Operating Income over 5 years is $78.9 million, with a median of -$1.3 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: Other Non Operating Income jumped 8198.17% in 2022, then plunged 5367.21% in 2025.
  • Over 5 years, Other Non Operating Income stood at $1.8 billion in 2022, then slumped by 114.28% to -$259.6 million in 2023, then soared by 101.31% to $3.4 million in 2024, then plunged by 1002.94% to -$30.7 million in 2025, then soared by 264.17% to $50.4 million in 2026.
  • The last three Other Non Operating Income figures came in at $50.4 million (Q2 2026), -$47.5 million (Q1 2026), and -$30.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.63 Bn 38.97 Bn 2.15 Bn
2 Viatris 19.19 Bn 18.30 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn
5 Bausch Health Companies 2.36 Bn 520.30 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 995.52 Mn 705.40 Mn 93.47 Mn
9 Fennec Pharmaceuticals 404.35 Mn 363.10 Mn 17.15 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.40 Mn
Mar 31, 2026 -47.50 Mn
Dec 31, 2025 -30.70 Mn
Sep 30, 2025 -67.10 Mn
Jun 30, 2025 -333.50 Mn
Mar 31, 2025 -99.30 Mn
Dec 31, 2024 3.40 Mn
Sep 30, 2024 10.20 Mn
Jun 30, 2024 -6.10 Mn
Mar 31, 2024 139.10 Mn
Dec 31, 2023 -259.60 Mn
Sep 30, 2023 92.00 Mn
Jun 30, 2023 107.50 Mn
Mar 31, 2023 69.90 Mn
Dec 31, 2022 1.82 Bn
Sep 30, 2022 20.60 Mn
Jun 30, 2022 -13.50 Mn
Mar 31, 2022 -33.70 Mn
Dec 31, 2021 21.90 Mn
Sep 30, 2021 -5.80 Mn